Navigation Links
ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012

SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release its unaudited financial results for the fourth quarter and full year ended December 31, 2011 on March 13, 2012. Management will host a conference call to discuss the results at 08:00AM New York Time on March 13, 2012 (08:00PM Beijing Time on March 13, 2012).

Conference Call

Mr. Michael Xin Hui, founder and Chief Executive Officer; Mr. William Dai, Chief Financial Officer; and Ms. Lan Xie, Vice President of Finance and Investor Relations, will discuss the results and take questions following the prepared remarks.

Dial-in details for the live conference call are as follows:

International: +1-718-354-1231
United States: +1-866-519-4004
United Kingdom: 080-8234-6646
Hong Kong: +852-2475-0994

Passcode: SHP

A live webcast of the conference call will be available on the investor relations section of the Company's website at:

A telephone replay of the call will be available for seven days from March 13, 2012, 11:00AM U.S. Eastern Time to March 20, 2012, 11:59PM U.S. Eastern Time. The dial-in details for the replay are as follows:

International: +61-2-8235-5000
Passcode: 57079920


ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit

For further information, please contact: 

Ms. Lan Xie
Vice President of Finance and Investor Relations

Brunswick Group
Josh Gartner
Phone: 86-10-5960-8600


SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma to Present at Cowens 32nd Annual Health Care Conference
2. ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
3. ShangPharma Announces Opening of New Facility to Support Lillys Pipeline
4. ShangPharma to Attend Two Upcoming Investor Conferences
5. ShangPharma Announces Third Quarter 2011 Results
6. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
7. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
8. ShangPharma Corporation Announces Resignation of a Director
9. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
10. ShangPharma Announces Up to $10 Million Share Repurchase Program
11. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
Post Your Comments:
(Date:10/9/2015)... , October 9, 2015 /PRNewswire/ ... --> The report summarizes ... and overall status of the manufacturers ... guidance and direction for companies and ... . --> ...
(Date:10/9/2015)... PHILADELPHIA , October 9, 2015 ... Conference, Oct. 7-9   ... information products and services, today launched ClinicalKey for Nursing ... authoritative content, tailored to meet the unique needs of nursing ... in Atlanta , Oct. 7-9, will have ...
(Date:10/9/2015)... 2015  Hi-Tech Pharmaceuticals ("Hi-Tech"), a leading global ... iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition ... , today announced that they have entered into ... to acquire iForce. The transaction will enhance Hi-Tech,s ... through iForce,s strong distribution network. Jared ...
Breaking Medicine Technology:
... BETHLEHEM, Pa., April 28, 2011 Particle Sciences ... EVA Performance Polymers, a leading supplier of ethylene ... together to streamline the development of drug-eluting devices. ... Celanese EVA Performance Polymers are working to provide ...
... A new study published online today in The ... (Avastin) is as effective as ranibizumab (Lucentis), the current ... degeneration (AMD). The results are from ... a pioneering comparative effectiveness trial made possible through funding ...
Cached Medicine Technology:
(Date:10/10/2015)... ... 10, 2015 , ... Well-known Eastern Pennsylvania personal injury law ... The National Law Journal for inclusion in their second annual list of America’s ... States who obtained the largest awards for their personal injury clients in 2014-2015. ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American ... Dean for Graduate Medical Education J. Michael Finley, DO, as the recipient of ... selected for his impact on graduate medical education opportunities for osteopathic residents, and ...
(Date:10/9/2015)... Aliso Viejo, CA (PRWEB) , ... October 09, 2015 , ... ... and easily add color pop grades to footage. A LUT is a Lookup Table ... color to the corresponding color indicated by the table. This pack comes with 60 ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Smoke alarms ... smoke alarms can cut the risk of dying in reported home fires in half. ... to make sure smoke alarms are property installed and maintained. , Half of home ...
(Date:10/9/2015)... Emeryville, CA (PRWEB) , ... October 09, 2015 , ... ... Training Center for the elite developmental camp at the Karolyi Ranch in Huntsville, Texas ... camp,” Katreece Stone, Head Over Heels girls team head coach and executive director, said. ...
Breaking Medicine News(10 mins):
... education (PE) in schools is one of the main ... childhood obesity, and PE-related injuries are on the rise. ... also increase the risk of injury. While recognizing that ... combating obesity, parents and school administrators should remain vigilant ...
... , , EAST BRUNSWICK, N.J., Aug. ... announced that the Company has received a complete response letter from ... can not at this time approve the Company,s Biologics License Application ... patients refractory to conventional therapy. , , ...
... simplex virus-2 (HSV-2), which causes genital herpes, increases the ... the genital skin sores and breaks that often result ... an immune-cell environment conducive to HIV infection that persists ... after they have been treated with oral doses of ...
... , , MANCHESTER, England, Aug. 2 ... turning to cosmetic surgery in increasing numbers, driven by the recent ... , Male cosmetic surgery rates are not only ... attached to male cosmetic surgery has all but disappeared, but in ...
... , , , CHICAGO, July ... AOC ), the leading global provider of risk management ... System, Agribusiness and Beverage Industry Report . The first annual ... these industries remain abreast of emerging issues and learn how peers ...
... FRANCISCO (August 1, 2009)Patients with second primary lung cancers ... cancer (OPLC), are more likely to have localized disease ... to receive surgical treatment rather than radiation treatment. However, ... specific mortality, Fox Chase Cancer Center researchers reported today ...
Cached Medicine News:
CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
Bras and Breast Support...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
Medicine Products: